+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Human Papillomavirus (HPV) Therapeutics Market 2019-2023 - Product Image

Global Human Papillomavirus (HPV) Therapeutics Market 2019-2023

  • ID: 4751593
  • Report
  • Region: Global
  • 113 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • ALLERGAN
  • Bausch Health
  • GlaxoSmithKline
  • Merck Sharp & Dohme
  • MORE
Technological advances in diagnostics to drive market growth. The diagnostic methods that are currently available in the market include Pap test, colposcopy, and HPV DNA test. Pap test is a screening procedure for cervical cancer, in which the presence of precancerous or cancerous cells is identified on the cervix. Colposcopy is a more advanced technique like a Pap test, which allows the examiner to take abnormal cell tissues from the cervix. The analysts have predicted that the human papillomavirus (HPV) therapeutics market will register a CAGR of nearly 9% by 2023.

Market Overview

Advent of vaccines

The global HPV therapeutics market witnessed strong advances in terms of prevention of diseases caused by HPV. This is primarily due to the increasing research on developing highly advanced vaccines with a longer half-life. Vaccines were proved to have strong efficacy toward the prevention of various disease-causing viruses and highly effective toward the prevention of various indications caused by HPV.

Multiple-dose schedules of vaccines

Despite the availability of vaccines for the prevention of indications caused by HPV, the market faces a challenge from their recurring doses. As the vaccines that are currently approved for HPV are developed for administering through invasive methods such as subcutaneous route, the need for multiple doses affects the patient adherence toward the completion of the dose cycle.

For the detailed list of factors that will drive and challenge the growth of the human papillomavirus (HPV) therapeutics market during the 2019-2023, view this report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including ALLERGAN and Bausch Health, the competitive environment is quite intense. Factors such as the advent of vaccines and the technological advances in diagnostics, will provide considerable growth opportunities to human papillomavirus (HPV) manufactures. ALLERGAN, Bausch Health, GlaxoSmithKline, Lee's Pharmaceutical Holdings, and Merck Sharp & Dohme are some of the major companies covered in this report.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • ALLERGAN
  • Bausch Health
  • GlaxoSmithKline
  • Merck Sharp & Dohme
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY ROA
  • Market segmentation by RoA
  • Comparison by RoA
  • Parenteral - Market size and forecast 2018-2023
  • Topical - Market size and forecast 2018-2023
  • Market opportunity by RoA
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 09: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 10: MARKET TRENDS

PART 11: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 12: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • ALLERGAN
  • Bausch Health
  • GlaxoSmithKline plc.
  • Lee's Pharmaceutical Holdings Limited
  • Merck Sharp & Dohme Corp.
PART 13: APPENDIX
  • Research methodology
  • List of abbreviations
List of Exhibits
Exhibit 01: Years in consideration
Exhibit 02: Global pharmaceuticals market
Exhibit 03: Segments of global pharmaceuticals market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: RoA - Market share 2018-2023 (%)
Exhibit 19: Comparison by RoA
Exhibit 20: Parenteral - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Parenteral - Year-over-year growth 2019-2023 (%)
Exhibit 22: Topical - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Topical - Year-over-year growth 2019-2023 (%)
Exhibit 24: Market opportunity by RoA
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2018-2023 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 29: North America - Year-over-year growth 2019-2023 (%)
Exhibit 30: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 32: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 34: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Decision framework
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: ALLERGAN - Vendor overview
Exhibit 46: ALLERGAN - Product segments
Exhibit 47: ALLERGAN - Organizational developments
Exhibit 48: ALLERGAN - Geographic focus
Exhibit 49: ALLERGAN - Segment focus
Exhibit 50: ALLERGAN - Key offerings
Exhibit 51: ALLERGAN - Key customers
Exhibit 52: Bausch Health - Vendor overview
Exhibit 53: Bausch Health - Product segments
Exhibit 54: Bausch Health - Organizational developments
Exhibit 55: Bausch Health - Geographic focus
Exhibit 56: Bausch Health - Segment focus
Exhibit 57: Bausch Health - Key offerings
Exhibit 58: Bausch Health - Key customers
Exhibit 59: GlaxoSmithKline plc. - Vendor overview
Exhibit 60: GlaxoSmithKline plc. - Business segments
Exhibit 61: GlaxoSmithKline plc. - Organizational developments
Exhibit 62: GlaxoSmithKline plc. - Geographic focus
Exhibit 63: GlaxoSmithKline plc. - Segment focus
Exhibit 64: GlaxoSmithKline plc. - Key offerings
Exhibit 65: GlaxoSmithKline plc. - Key customers
Exhibit 66: Lee's Pharmaceutical Holdings Limited - Vendor overview
Exhibit 67: Lee's Pharmaceutical Holdings Limited - Business segments
Exhibit 68: Lee's Pharmaceutical Holdings Limited - Organizational developments
Exhibit 69: Lee's Pharmaceutical Holdings Limited - Segment focus
Exhibit 70: Lee's Pharmaceutical Holdings Limited - Key offerings
Exhibit 71: Lee's Pharmaceutical Holdings Limited - Key customers
Exhibit 72: Merck Sharp & Dohme Corp. - Vendor overview
Exhibit 73: Merck Sharp & Dohme Corp. - Business segments
Exhibit 74: Merck Sharp & Dohme Corp. - Organizational developments
Exhibit 75: Merck Sharp & Dohme Corp. - Geographic focus
Exhibit 76: Merck Sharp & Dohme Corp. - Segment focus
Exhibit 77: Merck Sharp & Dohme Corp. - Key offerings
Exhibit 78: Merck Sharp & Dohme Corp. - Key customers
Exhibit 79: Validation techniques employed for market sizing
Exhibit 80: List of abbreviations
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • ALLERGAN
  • Bausch Health
  • GlaxoSmithKline
  • Merck Sharp & Dohme
  • MORE
Global Human Papillomavirus (HPV) Therapeutics Market 2019-2023

The analyst recognizes the following companies as the key players in the global human papillomavirus (HPV) therapeutics market: ALLERGAN, Bausch Health, GlaxoSmithKline, Lee's Pharmaceutical Holdings, and Merck Sharp & Dohme.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the technological advances in diagnostics.”

According to the report, one of the major drivers for this market is the advent of vaccines.

Further, the report states that one of the major factors hindering the growth of this market is the multiple-dose schedules of vaccines.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • ALLERGAN
  • Bausch Health
  • GlaxoSmithKline
  • Lee's Pharmaceutical Holdings
  • Merck Sharp & Dohme
Note: Product cover images may vary from those shown
Adroll
adroll